Jeffrey M Axten

Years Active: 2019-2021
Publications (10 Years): 2

GlaxoSmithKline

University of Pennsylvania (PHD)

This page only lists publications with an associated author ORCID identifier.

Affiliation History

GlaxoSmithKline

United States

Senior Scientific Director :: Medicinal Chemistry

Education History

University of Pennsylvania

United States

PHD :: Organic Chemistry

Philadelphia University

United States

BSC :: Chemistry

Publications

Shon A Koren, Matthew J Hamm, Ryan Cloyd, Sarah N Fontaine, Emad Chishti, Chiara Lanzillotta, Jennifer Rodriguez-Rivera, Alexandria Ingram, Michelle Bell, Sara M Galvis-Escobar, Nicholas Zulia, Fabio Di Domenico, Duc Duong, Nicholas T Seyfried, David Powell, Moriel Vandsburger, Tal Frolinger, Anika M S Hartz, John Koren, Jeffrey M Axten, Nicholas J Laping, Jose Francisco Abisambra
Broad Kinase Inhibition Mitigates Early Neuronal Dysfunction in Tauopathy. International journal of molecular sciences 22 (3) (2021)
Claudio Hetz, Jeffrey M Axten, John B Patterson
Pharmacological targeting of the unfolded protein response for disease intervention. Nature chemical biology 15 (8) (2019)

Jeffrey M Axten.css-eqlu8i{font-size:small;padding-left:4px;}